Check out the firms making headlines earlier than the bell:
Alibaba – The China e-commerce large noticed its shares plunge for the second straight session in a single day to their lowest stage since June. Alibaba introduced it was rising its share buyback program to $10 billion from $6 billion, however the transfer did not ease considerations a couple of regulatory crackdown by the Chinese authorities.
AT&T – "Wonder Woman 1984", produced by AT&T's Warner Bros. unit, led the weekend field workplace with $16.7 million in North American ticket gross sales. That quantity is low by historic requirements however is the strongest debut for any film since the pandemic started. "Wonder Woman" debuted concurrently in theaters and on the firm's "HBO Max" streaming service.
AstraZeneca – The drugmaker stated its Covid-19 vaccine candidate is believed by researchers to be efficient in opposition to a brand new variant of the virus that has helped drive a spike in circumstances in Britain. The vaccine is anticipated to win approval from U.Okay. regulators this week.
DoorDash – A Wall Street Journal column says the food-delivery service and rivals like Postmates might see their development impacted by a brand new legislation in California set to enter impact January 1. The legislation would require supply providers to have said agreements in locations with eating places to ship their meals. DoorDash did say in its IPO submitting that 95% of its order quantity this 12 months got here in transactions with partnered retailers.
Weibo – The Chinese social media firm reported an adjusted quarterly revenue of 66 cents per share, 6 cents above estimates, with income coming in above analysts' forecasts as effectively. Average energetic day by day customers throughout the quarter elevated to 224 million, in contrast with 216 million a 12 months earlier.
Myovant Sciences – The Switzerland-based drug firm struck a partnership with Pfizer to develop and commercialize the most cancers therapy Orgovoxy in Canada and the United States. The deal might doubtlessly be price greater than $4 billion to Myovant.
Tesla – India Transport Minister Nitin Gadkari advised the nationwide day by day newspaper Indian Express that the electric-car maker plans to start operations in India someday in 2021. Gadkari stated Tesla's involvement in India would start with auto gross sales however might broaden into manufacturing primarily based on response.
Boeing – A Reuters/Ipsos ballot discovered that about 39% of respondents had been aware of the two deadly crashes involving the Boeing 737 Max jet, about half of the quantity present in a previous ballot. However, when reminded of the crashes, greater than half say they’d in all probability keep away from flying the Max.
Sinovac – The China-based biopharmaceutical firm's Covid-19 vaccine candidate was stated by Turkish researchers to be 91.25% efficient. However, knowledge launched by researchers in Brazil say the vaccine's efficacy is between 50% and 90%.
IMV – The Canadian biopharmaceutical firm's shares are rising after it reported optimistic knowledge for its Covid-19 vaccine candidate, nonetheless in early examine levels. It will present an replace on the vaccine's progress throughout the first quarter of 2021.
primarily based on website supplies www.cnbc.com